Evaluating the Effect of Preemptive Administration of Maxigesic on Postoperative Shoulder Pain in Laparoscopic Cholecystectomy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011108

Enrollment

128

Registered

2025-11-06

Start date

2025-11-18

Completion date

Unknown

Last updated

2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Patients undergoing laparoscopic cholecystectomy under general anesthesia will be randomly assigned to either the study group (Maxigesic group) or the control group (normal saline). At the indu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligible participants will be adult patients (19–75 years) with ASA physical status I undergoing laparoscopic cholecystectomy under general anesthesia at Konkuk University Medical Center.

Exclusion criteria

Exclusion criteria: 1) urgent or emergent case, 2) history of drug abuse, 3) QT prolongation on preoperative electrocardiography, 4) any current medication, 5) previous abdominal surgery and 6) other concurrent surgery, 7) pregnancy.

Design outcomes

Primary

Measure	Time frame
Laparoscopic surgery–related shoulder pain	—

Secondary

Measure	Time frame
Postoperative nausea and vomiting	—

Countries

Korea, Republic of

Contacts

Public ContactSeung-wan Hong

Konkuk University Medical Center

20150077@kuh.ac.kr+82-2-2030-5448

Outcome results